GAM
ZOM

Gotham Asset Management’s Zomedica Corp. ZOM Stock Holding History

Gotham Asset Management’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-149,269
Closed -$236K – 1159
2021
Q1 		$236K Buy
+149,269
New +$244K 0.01% 909

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Gotham Asset Management's ZOM Position: Q2 2021 in Review

Gotham Asset Management sold out of Zomedica Corp. (ZOM) in Q2 2021, closing a stake of 149,269 shares — an estimated $236K sold.

Gotham Asset Management first reported a position in ZOM in Q1 2021 and held it in 1 quarter. The position peaked at $236K in Q1 2021. 106 funds tracked by Wall St. Rank hold ZOM as of Q2 2021.

  • Gotham Asset Management reported no remaining Zomedica Corp. position as of Q2 2021 after selling out during the quarter.
  • Gotham Asset Management sold 149,269 Zomedica Corp. shares in Q2 2021, an estimated $236K.
  • Gotham Asset Management first reported a position in Zomedica Corp. in Q1 2021 and held it in 1 quarter.
  • Gotham Asset Management's Zomedica Corp. position peaked at $236K in Q1 2021.
  • 106 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2021.

Based on Gotham Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.